Arbutus Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABUS and other ETFs, options, and stocks.About ABUS
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV).
ABUS Key Statistics
Stock Snapshot
As of today, Arbutus Biopharma(ABUS) shares are valued at $4.37. The company's market cap stands at 848.15M, with a P/E ratio of -19.93.
During the trading session on 2026-03-24, Arbutus Biopharma(ABUS) shares reached a daily high of $4.39 and a low of $4.37. At a current price of $4.37, the stock is 0.0% higher than the low and still -0.5% under the high.
Trading activity shows a volume of 2.34K, compared to an average daily volume of 2.68M.
Over the past 52 weeks, Arbutus Biopharma(ABUS) stock has traded between a high of $5.10 and a low of $2.71.
Over the past 52 weeks, Arbutus Biopharma(ABUS) stock has traded between a high of $5.10 and a low of $2.71.
ABUS News
An announcement from Arbutus Biopharma ( (ABUS) ) is now available. Arbutus Biopharma reported a solid financial position at year-end 2025, with $91.5 million...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.